Table 3

Surgery rates and factors associated with receiving surgery by topography
Variable C15 Surgical Rate (per 100) aOR#(95%CI) C15&C160 Surgical rate (per 100) aOR (95% CI)#
Age at diagnosis (years)
<60 25.0 8.96 (5.63-14.3)* 28.4 8.12 (5.64-11.7)*
60–69 23.2 9.85 (6.25-15.5)* 26.8 8.48 (5.94-12.1)*
70–79 11.1 3.99 (2.52-6.32)* 15.4 4.20 (2.94-6.00)*
80+ 3.1 Referent 3.9 Referent
Gender
Female 10.2 Referent 11.3 Referent
Male 16.8 1.04 (0.78-1.38) 21.2 1.31 (1.05-1.64)*
Country of Birth
Australia 13.8 Referent 17.9 Referent
Other 16.5 0.90 (0.70-1.16) 19.1 0.76 (0.62-0.92)*
Histology group
SCC 11.4 0.40 (0.31-0.52)* 11.7 0.41 (0.32-0.51)*
Adenocarcinomas 20.1 Referent 23.6 Referent
Other 3.8 0.28 (0.17-0.48)* 5.9 0.36 (0.24-0.53)*
Degree of Spread
Localised 15.3 6.06 (4.06-9.06)* 18.6 5.50 (4.08-7.41)*
Regional 33.5 12.34 (8.22-18.52)* 38.1 10.29 (7.67-13.79)*
Distant 6.1 Referent 6.4 Referent
Unknown 5.0 2.38 (1.42-3.98)* 5.5 1.71 (1.14-2.56)*
Tumour location
Upper 5.8 0.22 (0.12-0.39) 5.8 0.22 (0.13-0.40)
Mid 10.9 0.51 (0.34-0.76) 10.9 0.52 (0.35-0.77)
Distal 21.5 Referent 21.5 26.4 Referent 1.10 (0.88-1.36)
Charlson comorbidity
0 11.4 Referent 14.1 Referent
1,2 9.7 0.52 (0.32-0.83)* 11.9 0.56 (0.39-0.80)*
3+ 0 - 5.0 0.25 (0.06-1.14)
Hospital admission
Private co-located 43.1 Referent 46.5 Referent
Private non co-located 4.4 0.06 (0.04-0.10)* 6.2 0.07 (0.05-0.10)*
Public co-located 34.0 0.78 (0.53-1.16) 37.8 0.80 (0.59-1.08)
Public non co-located 20.6 0.26 (0.16-0.42)* 26.5 0.26 (0.18-0.38)*
Hospital area service
Area 1 18.1 2.30 (1.38-3.84)* 23.6 2.99 (2.03-4.39)*
Area 2 16.2 0.73 (0.48-1.09) 19.4 0.80 (0.59-1.09)
Area 3 25.8 Referent 28.6 Referent
Area 4 19.6 1.29 (0.86-1.93) 23.8 1.58 (1.16-2.17)*
Area 5 12.2 1.71 (0.99-2.97) 16.5 1.92 (1.27-2.90)*
Area 6 3.5 0.82 (0.38-1.77) 4.6 0.88 (0.49-1.56)
Area 7 5.1 0.71 (0.34-1.47) 8.2 0.98 (0.59-1.65)
Area 8 0.0 - 0.0 -

#Adjusted for age-group, gender, histology, country of birth, histology, degree-of-spread, tumour location, hospital admitted, area of service, Charlson comorbidity index.

* Significant at P<0.05 (two-tailed) level.

Stavrou et al.

Stavrou et al. BMC Health Services Research 2012 12:384   doi:10.1186/1472-6963-12-384

Open Data